David H. Persing, EVP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 20,138 shares at $52.55 ($1.1M) on 2014-10-30, disclosed to the SEC on 2014-10-31.
Scheduled sale ($1.1M) by EVP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.90 | 138 | $7K | 0.7% |
| 2 | $52.55 | 5,000 | $263K | 24.5% |
| 3 | $53.07 | 5,000 | $265K | 24.7% |
| 4 | $53.60 | 5,000 | $268K | 25.0% |
| 5 | $54.14 | 5,000 | $271K | 25.2% |
| Total | $53.33 avg | 20,138 |
| $1.1M |
| 100% |
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |